» Articles » PMID: 32365420

VRK1 (Y213H) Homozygous Mutant Impairs Cajal Bodies in a Hereditary Case of Distal Motor Neuropathy

Overview
Specialty Neurology
Date 2020 May 5
PMID 32365420
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Distal motor neuropathies with a genetic origin have a heterogeneous clinical presentation with overlapping features affecting distal nerves and including spinal muscular atrophies and amyotrophic lateral sclerosis. This indicates that their genetic background is heterogeneous.

Patient And Methods: In this work, we have identified and characterized the genetic and molecular base of a patient with a distal sensorimotor neuropathy of unknown origin. For this study, we performed whole-exome sequencing, molecular modelling, cloning and expression of mutant gene, and biochemical and cell biology analysis of the mutant protein.

Results: A novel homozygous recessive mutation in the human VRK1 gene, coding for a chromatin kinase, causing a substitution (c.637T > C; p.Tyr213His) in exon 8, was detected in a patient presenting since childhood a progressive distal sensorimotor neuropathy and spinal muscular atrophy syndrome, with normal intellectual development. Molecular modelling predicted this mutant VRK1 has altered the kinase activation loop by disrupting its interaction with the C-terminal regulatory region. The p.Y213H mutant protein has a reduced kinase activity with different substrates, including histones H3 and H2AX, proteins involved in DNA damage responses, such as p53 and 53BP1, and coilin, the scaffold for Cajal bodies. The mutant VRK1(Y213H) protein is unable to rescue the formation of Cajal bodies assembled on coilin, in the absence of wild-type VRK1.

Conclusion: The VRK1(Y213H) mutant protein alters the activation loop, impairs the kinase activity of VRK1 causing a functional insufficiency that impairs the formation of Cajal bodies assembled on coilin, a protein that regulates SMN1 and Cajal body formation.

Citing Articles

Nuclear functions regulated by the VRK1 kinase.

Lazo P Nucleus. 2024; 15(1):2353249.

PMID: 38753965 PMC: 11734890. DOI: 10.1080/19491034.2024.2353249.


Pathogenic effects of Leu200Pro and Arg387His VRK1 protein variants on phosphorylation targets and H4K16 acetylation in distal hereditary motor neuropathy.

Campos-Diaz A, Morejon-Garcia P, Monte-Serrano E, Ros-Pardo D, Marcos-Alcalde I, Gomez-Puertas P J Mol Med (Berl). 2024; 102(6):801-817.

PMID: 38554151 PMC: 11106162. DOI: 10.1007/s00109-024-02442-8.


Dysfunctional Homozygous VRK1-D263G Variant Impairs the Assembly of Cajal Bodies and DNA Damage Response in Hereditary Spastic Paraplegia.

Morejon-Garcia P, Keren B, Marcos-Alcalde I, Gomez-Puertas P, Mochel F, Lazo P Neurol Genet. 2021; 7(5):e624.

PMID: 34504951 PMC: 8422991. DOI: 10.1212/NXG.0000000000000624.


VRK1 Depletion Facilitates the Synthetic Lethality of Temozolomide and Olaparib in Glioblastoma Cells.

Navarro-Carrasco E, Lazo P Front Cell Dev Biol. 2021; 9:683038.

PMID: 34195200 PMC: 8237761. DOI: 10.3389/fcell.2021.683038.


VRK1 Phosphorylates Tip60/KAT5 and Is Required for H4K16 Acetylation in Response to DNA Damage.

Garcia-Gonzalez R, Morejon-Garcia P, Campillo-Marcos I, Salzano M, Lazo P Cancers (Basel). 2020; 12(10).

PMID: 33076429 PMC: 7650776. DOI: 10.3390/cancers12102986.

References
1.
Vinograd-Byk H, Sapir T, Cantarero L, Lazo P, Zeligson S, Lev D . The spinal muscular atrophy with pontocerebellar hypoplasia gene VRK1 regulates neuronal migration through an amyloid-β precursor protein-dependent mechanism. J Neurosci. 2015; 35(3):936-42. PMC: 6605533. DOI: 10.1523/JNEUROSCI.1998-14.2015. View

2.
Shin J, Chakraborty G, Bharatham N, Kang C, Tochio N, Koshiba S . NMR solution structure of human vaccinia-related kinase 1 (VRK1) reveals the C-terminal tail essential for its structural stability and autocatalytic activity. J Biol Chem. 2011; 286(25):22131-8. PMC: 3121357. DOI: 10.1074/jbc.M110.200162. View

3.
Girard C, Neel H, Bertrand E, Bordonne R . Depletion of SMN by RNA interference in HeLa cells induces defects in Cajal body formation. Nucleic Acids Res. 2006; 34(10):2925-32. PMC: 1474063. DOI: 10.1093/nar/gkl374. View

4.
El-Bazzal L, Rihan K, Bernard-Marissal N, Castro C, Chouery-Khoury E, Desvignes J . Loss of Cajal bodies in motor neurons from patients with novel mutations in VRK1. Hum Mol Genet. 2019; 28(14):2378-2394. DOI: 10.1093/hmg/ddz060. View

5.
Banks G, Bros-Facer V, Williams H, Chia R, Achilli F, Bryson J . Mutant glycyl-tRNA synthetase (Gars) ameliorates SOD1(G93A) motor neuron degeneration phenotype but has little affect on Loa dynein heavy chain mutant mice. PLoS One. 2009; 4(7):e6218. PMC: 2704870. DOI: 10.1371/journal.pone.0006218. View